Dalumingo, Resulne .

HRN: 24-41-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2024
CEFUROXIME 1.5GM (VIAL)
02/20/2024
02/20/2024
IV
1.5g
Now
Loading Dose
Waiting Final Action 
02/20/2024
CLINDAMYCIN 300MG (CAP)
02/20/2024
02/26/2024
IV
300mg
Q8
S/P LTCS With IUD Insertion
Waiting Final Action 
02/20/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
02/20/2024
02/26/2024
IV
240mg
Q24
S/P LTCS With IUD Insertion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: